JPMORGAN CHASE & CO

Position in GPCR — Structure Therapeutics Inc.

CIK 19617 NEW YORK, NY

Position in GPCR

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$213,818

-$10,043,284 QoQ

Shares Held

3,984

-98.1% QoQ

Ownership

0.006%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#151

of 190 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 35% Shared 0% None 65%

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,940,256,291 across 425 Biotechnology names. GPCR ranks #231 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,517,600	$3,237,487,438
2	REGN	Regeneron Pharmaceuticals, Inc.	3,774,199	$2,353,364,036
3	INSM	INSMED Inc	10,428,170	$1,111,851,478
4	ALNY	Alnylam Pharmaceuticals, Inc.	2,675,517	$805,410,876
5	RVMD	Revolution Medicines, Inc.	3,298,066	$617,661,794
6	RYTM	Rhythm Pharmaceuticals, Inc.	2,652,746	$294,534,385
7	JAZZ	Jazz Pharmaceuticals plc	1,160,786	$279,714,596
8	QURE	uniQure N.V.	4,867,755	$224,208,791

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$213,818	3,984	-98.1%	Shares	Other	2026-08-12
2026-03-31	$10,257,102	212,803	+1542.5%	Shares	Other	2026-05-13
2025-12-31	$901,089	12,956	-77.7%	Shares	Other	2026-02-11
2025-09-30	$1,628,144	58,148	+37.0%	Shares	Other	2025-11-07
2025-06-30	$880,244	42,442	-68.4%	Shares	Other	2025-08-12
2025-03-31	$2,323,675	134,239	+315.4%	Shares	Other	2025-05-12
2024-12-31	$876,381	32,315	-4.8%	Shares	Other	2025-02-12
2024-09-30	$1,489,450	33,936	+302.3%	Shares	Defined	2024-12-26
2024-06-30	$331,280	8,436	-65.5%	Shares	Other	2024-12-26
2024-03-31	$1,047,111	24,431	+211.4%	Shares	Other	2024-12-26
2023-12-31	$319,802	7,846	-80.2%	Shares	Other	2024-12-26
2023-09-30	$1,994,564	39,559	—	Shares	Other	2023-11-14
No filing history on record for this holder in this stock.